Advanced endoscopic therapeutics in Barrett’s neoplasia: where are we now and where are we heading?

Abstract

Over the last 10 years, there have been considerable changes in how we manage Barrett’s neoplasia, with the shift away from conventional surgery and moving toward endotherapy for treating dysplasia and early cancer. In this editorial, we will review these changes and look forward to the possible developments which may occur over the next decade.

Keywords:

• ablation
• Barrett’s
• dysplasia
• endoscopic mucosal resection
• endoscopic submucosal dissection
• intra-mucosal cancer
• neoplasia
• radiofrequency ablation
• submucosal cancer

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.

No writing assistance was utilized in the production of this manuscript.